Kathryn E. Falberg serves as Executive at HALOZYME THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Kathryn E. Falberg has executed 166 insider transactions totaling $91.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 30, 2010 involved purchasing 25,689 shares valued at $219.1K.
Kathryn E. Falberg currently holds 96,910 shares of HALOZYME THERAPEUTICS INC (HTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathryn E. Falberg has been a net seller of HTI stock. They have purchased $13.3M and sold $77.9M worth of shares.
Kathryn E. Falberg's most recent insider trade was on Aug 30, 2010, when they purchased 25,689 shares at $8.53 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 16, 2009 | ABIO | $360 | Sale | 100 | $3.60 | Discretionary |
| Jun 16, 2009 | ABIO | $24.2K | Sale | 6,700 | $3.61 | Discretionary |
| Jun 16, 2009 | ABIO | $1.8K | Sale | 500 | $3.62 | Discretionary |
| Jun 16, 2009 | ABIO | $5.8K | Sale | 1,600 | $3.62 | Discretionary |
| Jun 16, 2009 | ABIO | $7.9K | Sale | 2,200 | $3.58 | Discretionary |
| Jun 16, 2009 | ABIO | $1.8K | Sale | 500 | $3.65 | Discretionary |
| Jun 16, 2009 | ABIO | $5.1K | Sale | 1,400 | $3.66 | Discretionary |
| Jun 16, 2009 | ABIO | $4.8K | Sale | 1,300 | $3.67 | Discretionary |
| Jun 16, 2009 | ABIO | $1.8K | Sale | 500 | $3.68 | Discretionary |
| Jun 16, 2009 | ABIO | $21.5K | Sale | 6,000 | $3.59 | Discretionary |
| Jun 16, 2009 | ABIO | $728 | Sale | 200 | $3.64 | Discretionary |
| May 7, 2009 | HALO | $0 | Award | 20,000 | $N/A | Discretionary |
| May 8, 2008 | HALO | $74.1K | Award | 15,000 | $4.94 | Discretionary |
| May 15, 2007 | HTI | $155.6K | Award | 15,000 | $10.37 | Discretionary |